Insulet (PODD) Tops Q4 EPS by 10c
Get Alerts PODD Hot Sheet
Price: $147.48 -2.06%
Revenue Growth %: +18.1%
Financial Fact:
Cost of revenue: 39.23M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +18.1%
Financial Fact:
Cost of revenue: 39.23M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q4 EPS of $0.42, $0.10 better than the analyst estimate of $0.32. Revenue for the quarter came in at $307.7 million versus the consensus estimate of $301.06 million.
GUIDANCE:
For the year ending December 31, 2022, the Company expects revenue growth in the range of 12% to 16%.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Dell’s earning report was bullish for Intel CPU demand, analyst says
- UBS Upgrades E.ON SE (EOAN:GR) (EONGY) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share